DGX Stock: Quest Diagnostics Incorporated Stock Price, Analysis & Insights
Get live DGX stock price $204.53, comprehensive Quest Diagnostics Incorporated stock analysis, charts, news, and expert forecast. Real-time DGX stock data and investment insights.
Loading chart data...
Quest Diagnostics Incorporated (DGX) Overview
Quest Diagnostics Incorporated (DGX) is a publicly traded company in the Healthcare sector , specifically within the Medical - Diagnostics & Research industry . As of the latest trading session, DGX trades at $204.53 with a market capitalization of 22.64B . Over the past 52 weeks, DGX has traded between $164.65 and $213.50 , with the current price positioned at approximately 82% of this range ....
Key Takeaways
- Operates in the Healthcare sector (Medical - Diagnostics & Research)
- Market cap: 22.64B
- Current price: $204.53
- 52-week range: $164.65 - $213.50
- P/E ratio: 22.60
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involv...
Company Information
- CEO
- James E. Davis
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 55000
Contact Information
- Address
- 500 Plaza Drive
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 22.6)
✓ Lower volatility stock (Beta: 0.59) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Quest Diagnostics Incorporated shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Quest Diagnostics Incorporated
- ⚠Investors should consider how Quest Diagnostics Incorporated fits within their overall portfolio allocation
Market Cap
22.64B
P/E Ratio (TTM)
22.60
Beta
0.59
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare DGX with peer companies:
- Price
- $151.82
- Market cap
- 11.62B
- Price
- $160.03
- Market cap
- 24.21B
- Price
- $103.23
- Market cap
- 20.62B
- Price
- $271.24
- Market cap
- 22.24B
- Price
- $466.79
- Market cap
- 13.33B
- Price
- $166.36
- Market cap
- 14.33B
- Price
- $553.14
- Market cap
- 23.48B
- Price
- $371.15
- Market cap
- 24.19B
- Price
- $334.66
- Market cap
- 23.64B
- Price
- $89.63
- Market cap
- 17.34B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.